Sort
16,179 grants matching “malaria”
University of Washington Vaccine and Treatment Evaluation Unit
$2,527,789Anna Wald · University Of Washington · UM1 · FY2025 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$2,516,717Anna Wald · University Of Washington · UM1 · FY2021 · AI
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$2,515,037Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2011 · PS
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$2,510,151Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Environmental factors in placental pathology: a new diagnostic method based on umbilical vessel wave mechanics
$2,507,213John G Sled · Hospital For Sick Chldrn (Toronto) · U01 · FY2015 · HD
IeDEA West -Africa collaboration
$2,496,231Francois Dabis · Adera · U01 · FY2012 · AI
Nitric Oxide and Endothelial Function in Patients with Malaria
$2,494,767Hans Ackerman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,492,267David S Stephens · Emory University · UM1 · FY2020 · AI
THE COMPLETION OF CMC DEVELOPMENT AND PRODUCTION OF PILOT-SCALE CGMP LOSTS OF VLPM01, A MALARIA VACCINE CANDIDATE
$2,490,865Vlp Therapeutics, Inc. · · FY2016 · Department of Defense
Translational Approaches for Pathogens of Human Significance
$2,490,273Jennifer F Friedman · Rhode Island Hospital · P20 · FY2025 · GM
Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
$2,481,382Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Optimizing malaria transmission-blocking vaccines with improved platforms
$2,473,905Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Pathogenesis of Acute CNS infection and injury
$2,465,900Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria
$2,465,529Michael T Ferdig · University Of Notre Dame · P01 · FY2025 · AI
Malaria immunology
$2,464,408Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Development of Malaria Transmission-Blocking Drugs
$2,453,144Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
DEVELOPMENT OF SAFER DRUGS FOR MALARIA IN U.S. TROOPS, CIVILIAN PERSONNEL AND TRAVELERS"
$2,447,938The University Of Mississippi · · FY2013 · Department of the Army
Malaria Vaccine: AMA1-C1
$2,446,041Louis Miller · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa
$2,436,893Diane V Havlir · University Of California, San Francisco · P01 · FY2010 · HD
Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
$2,432,642Myriam Gorospe · National Institute On Aging · ZIA · FY2021 · AG
Pathogenesis of CNS infection and injury
$2,430,939Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Harnessing the Power of Experimental Genetic Crosses to Probe Drug Resistance in Malaria
$2,430,648Michael T Ferdig · University Of Notre Dame · P01 · FY2024 · AI
Mapping the combinatorial olfactory inputs that drive mosquito host attraction
$2,430,000Carolyn Sarah McBride · Princeton University · DP2 · FY2018 · AI
The Genome Analysis Core
$2,424,710Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$2,423,669Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI